Journals / Türk Nefroloji Diyaliz ve Transplantasyon Dergisi / 2014 / Cilt: 23 - Sayı: 1

Kardiyoloji pratiğinde albüminüri/proteinüri: kardiyologlar idrar testi istiyorlar mı?

Albuminuria/proteinuria in cardiology practice: do cardiologists ask for urine testing?

Pages
46–50
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Omission of such an important, but easy to measure parameter in assessing risk status may jeopardize the overall care of these patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Even a small amount of albumin in urine is predictive of cardiovascular morbidity and mortality, not only in patients with diabetes or hypertension but also in the general population.
📊
Key Findings & Data:The total number of urine tests for evaluating albuminuria/ proteinuria ordered for the patients during the 12 months preceding angiography was recorded.
💡
Conclusion & Impact:Omission of such an important, but easy to measure parameter in assessing risk status may jeopardize the overall care of these patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: Even a small amount of albumin in urine is predictive of cardiovascular morbidity and mortality, not only in patients with diabetes or hypertension but also in the general population. We hypothesized that determination of urinary protein excretion is usually not included in the laboratory work-up of most patients in cardiology practice. MATERIAL and METHODS: One thousand forty two patients who underwent coronary angiography during a one-year period were included. The total number of urine tests for evaluating albuminuria/ proteinuria ordered for the patients during the 12 months preceding angiography was recorded. Types of urine tests were recorded as routine dipstick urinalysis, 24 hour urine collection for albuminuria or proteinuria, and protein/creatinine or albumin/creatinine ratios. RESULTS: No urine tests were ordered in 642 (61.6%) patients. Spot urinalysis for dipstick proteinuria was the most common test for proteinuria evaluation (35.7% of the patients). 24-hour urine collection for albuminuria/proteinuria was ordered in 56 (5.4%) patients and spot urine albumin or protein/ creatinine ratio in 56 (5.4%) patients. CONCLUSION: This study has shown that urine testing is rarely ordered in a high-risk population who had coronary angiography. Omission of such an important, but easy to measure parameter in assessing risk status may jeopardize the overall care of these patients.

Özet

AMAÇ: Çok sayıda çalışmada, idrarda az miktarda albümin atılımının bile kardiyovasküler olayların ve tüm nedenlere ve kardiyovasküler olaylara bağlı mortalitenin önemli bir belirteci olduğu gösterilmiştir. İdrarda albüminüri incelemesi, yüksek riskli durumlarda standart bakımın bir kalite belirteci olarak kabul edilebilir. Bu çalışmada, koroner anjiyografi yapılan hastalarda idrar testinin istenme sıklığı incelendi. GEREÇ ve YÖNTEMLER: Bir yıllık süre içinde koroner anjiyografi yapılan 1044 hasta çalışmaya dahil edildi. İşlem tarihinden önceki on iki aylık dönemde proteinüri saptamak için yapılmış olan idrar tetkikleri hastanenin bilgisayarlı tıbbi kayıt sistemi kullanılarak kaydedildi. İdrar tetkikleri; spot idrarda dipstik testi, spot idrar albümin/kreatinin veya protein/kreatinin oranı ve yirmidört saatlik idrarda albüminüri veya proteinüri olarak sınıflandırıldı. BULGULAR: Çalışmaya alınan hastaların 642 sinde (%61,6) herhangi bir yöntemle proteinüri incelenmemişti. Proteinüri incelemek için kullanılan en sık yöntem spot idrar dipstik testiydi. (%35,7). 24 saatlik idrarda albümin veya protein 56 hastada (%5,4) ve spot idrarda albümin/kreatinin oranı veya protein/kreatinin oranı 56 hastada (%5,4) incelenmişti. SONUÇ: Bu çalışmada, koroner anjiyografi yapılan yüksek riskli hastalarda idrar testinin nadiren kullanıldığı gösterilmiştir. Risk değerlendirmesinde bu kadar önemli ve aynı zamanda kolay ölçülebilir bir parametrenin kullanılmaması, bu hastaların tedavi yönetiminde eksikliğe sebep olabilir.

🔖

Cite This Article

YILDIRIM, T., ARICI, M., ERDEM, Y., TURGAN, Ç., YILMAZ, R., ÖZKUTLU, H., AYBAL, A. K., PİŞKİNPAŞA, S. (2022). Kardiyoloji pratiğinde albüminüri/proteinüri: kardiyologlar idrar testi istiyorlar mı?. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, Cilt: 23 - Sayı: 1, 46–50. https://ajindex.com/articles/636266

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Chobanian AV, Bakris GL, Black HR, Cushman WC, GreenIzzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung,Blood Institute; National High Blood Pressure Education Program Coordinating Committee: Seventh report of the Joint National Committee on Prevention, Detection, evaluation, and treatmenthigh blood pressure. Hypertension 2003; 42: 1206-1252
  2. Mosca L, Banka CL, Benjamin EJ, Berra K, Bushnell C, Dolor RJ, Ganiats TG, Gomes AS, Gornik HL, Gracia C, Gulati M, Haan CK, Judelson DR, Keenan N,Kelepouris E, Michos ED, Newby LK, Oparil S, Ouyang P, Oz MC, Petitti D, Pinn VW, RedbergScott R, Sherif K, Smith SC Jr, Sopko G, Steinhorn RH, StoneTaubert KA, Todd BA, Urbina E, Wenger NK; Expert Panel/Writing Group; American Heart Association; American Academy of Family Physicians; American College of Obstetricians and Gynecologists; American College of Cardiology Foundation; Society of Thoracic Surgeons; American Medical Women’s Association; CentersDisease Control and Prevention; Office of Research on Women’s Health; Association of Black Cardiologists; American CollegePhysicians; World Heart Federation; National Heart, Lung,Blood Institute; American College of Nurse Practitioners: Evidence based guidelines for cardiovascular disease prevention in women. Circulation 2007; 115: 1481-1501
  3. Deveci OS, Kabakci G, Tulumen E, Okutucu S, Aksoy H, Kaya EB, Canpolat U, Aytemir K, Tokgozoglu L, Oto A: The relationship between microalbuminuria and the presence and extent of coronary atherosclerosis. Angiology 2010; 61: 184-191
  4. Hoseini VN, Rasouli M: Microalbuminuria correlates withprevalence and severity of coronary artery disease in non-diabetic patients. Cardiol J 2009; 16: 142-145
  5. Mercado N, Brugts JJ, Ix JH, Shlipak MG, Dixon SR, GershLemos PA, Guarneri M, Teirstein PS, Wijns W, Serruys PW, Boersma E, O’Neill WW: Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous coronary intervention (Data from the evaluationoral xemilofiban in controlling thrombotic events [EXCITE] trial). Am J Cardiol 2008; 102: 1151-1155
  6. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, V